✦ LIBER ✦

Comparison of Different Tumor Response Criteria in Patients with Hepatocellular Carcinoma After Systemic Therapy with the Multikinase Inhibitor Sorafenib

✍ Scribed by Spira, Daniel; Fenchel, Michael; Lauer, Ulrich M.; Claussen, Claus D.; Gregor, Michael; Bitzer, Michael; Horger, Marius

Book ID: 121885664
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 216 KB
Volume: 18
Category: Article
ISSN: 1076-6332
DOI: 10.1016/j.acra.2010.08.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early MRI response monitoring of patient

Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib

✍ Marius Horger; Ulrich M Lauer; Christina Schraml; Christoph P Berg; Ursula Koppe 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 451 KB

Comparison of tumor response by Response

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

✍ Julien Edeline; Eveline Boucher; Yan Rolland; Elodie Vauléon; Marc Pracht; Chris 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

## Abstract ## BACKGROUND: A significant improvement in overall survival (OS) was demonstrated in patients with advanced hepatocellular carcinoma (HCC) who received sorafenib (Sor) in the Sorafenib HCC Assessment Randomized Protocol (SHARP) study, in contrast to a response rate (RR) of 2% assessed

639 SINGLE NUCLEOTIDE POLYMORPHISM ASSOC

639 SINGLE NUCLEOTIDE POLYMORPHISM ASSOCIATED WITH TUMOR RESPONSE TO THE COMBINED THERAPY WITH TRANSARTERIAL CHEMOEMBOLIZATION AND SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

✍ J.-H. Lee; Y.-H. Chung; J.A. Kim; E.-S. Shin; D. Lee; J.H. Shim; H.C. Lee; J.H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

6576 POSTER Phase II Safety Study of the

6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma

✍ Bolondi, L.; Tak, W.Y.; Gasbarrini, A.; Santoro, A.; Colombo, M.; Lim, H.Y.; Maz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

The Role of Functional MR Imaging in the

The Role of Functional MR Imaging in the Assessment of Tumor Response after Chemoembolization in Patients with Hepatocellular Carcinoma

✍ Kamel, Ihab R.; Bluemke, David A.; Eng, John; Liapi, Eleni; Messersmith, Wells; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 207 KB

261 VASCULAR ENDOTHELIAL GROWTH FACTOR A

261 VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PREDICTOR OF RESPONSE TO THE COMBINED THERAPY WITH SORAFENIB AND TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

✍ Lee, D.; Chung, Y.-H.; Kim, J.A.; Lee, J.-H.; Shin, E.-S.; Shim, J.-H.; Lee, H.C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB